Rationale: A crucial step in atherogenesis is the infiltration of the subendothelial space of large arteries by monocytes where they differentiate into macrophages and transform into lipid-loaded foam cells. Macrophages are heterogeneous cells that adapt their response to environmental cytokines. Th1 cytokines promote monocyte differentiation into M1 macrophages, whereas Th2 cytokines trigger an "alternative" M2 phenotype.
A crucial step in atherogenesis is the infiltration of monocytes within the subendothelial space of large arteries and their differentiation into macrophages. In early plaques, recruited macrophages play reparatory roles via the phagocytosis of oxidized lipids and apoptotic cells. However, during atherosclerosis progression, macrophages contribute to foam cell formation, lesion growth, plaque rupture and thrombosis by secreting immune-inflammatory factors, growth factors, proteolytic enzymes and tissue factor. 1 One of the most important functions of macrophages in the context of atherosclerosis is the handling of lipids, especially cholesterol. The maintenance of macrophage cholesterol homeostasis is of critical importance in the pathogenesis of atherosclerosis, because an imbalance between cholesterol influx and efflux leads to an excessive accumulation of cholesterol in macrophages and their transformation into foam cells. 2, 3 Macrophage scavenger receptors, including scavenger receptor (SR)-A, CD36, and lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX)-1, mediate the uptake of modified LDL lipoproteins, including oxidized LDL. Within the macrophages, modified LDL-derived cholesteryl esters are hydrolyzed in lysosomes by the lysosomal acid lipase (LAL). The released unesterified cholesterol traffics to and integrates in the plasma membrane. The excess of cholesterol is transported back to the endoplasmic reticulum where it is re-esterified by acyl-CoA:cholesterol acyltransferase (ACAT)-1 and stored as lipid droplets. 4 Cellular cholesterol at the plasma membrane is available for efflux, a highly regulated process mediated by specific proteins, including ATP-binding cassette (ABC) transporters (ABCA1 and ABCG1/ABCG4) 5 and apolipoprotein (Apo)E. 6 Besides their role in lipid handling and the immuneinflammatory response, macrophages are also involved in phagocytosis of opsonized bacteria and pathogens and efferocytosis, the clearance of apoptotic cells and debris, because they express receptors and adapters which recognize the "eat-me" signals at the surface of dying cells. 7 Ingestion of apoptotic cells generally triggers an antiinflammatory response. 8 Hence, atherosclerosis may be caused not only by a sustained proinflammatory reaction, but also by the failure of antiinflammatory control mechanisms.
Macrophages are heterogeneous cells, which adapt their response to environmental cytokines and microbial products. Whereas Th1 cytokines (interferon ␥ and interleukin [IL]-1␤) or bacterial lipopolysaccharide induce a "classic" activation profile (M1), the Th2 cytokines IL-4 and IL-13 induce an "alternative" activation (M2) of macrophages. Macrophages are plastic cells because they can switch from the M1 to M2 state and vice versa, on specific signals. 9 M1 macrophages produce proinflammatory cytokines, such as tumor necrosis factor (TNF)␣, IL-6 and IL-12, 9 whereas M2 macrophages dampen this inflammatory Th1 response by producing antiinflammatory factors (IL-10, transforming growth factor-␤, IL-1 receptor antagonist), thus promoting angiogenesis and tissue repair. 9, 10 Macrophage functions are under the control of several transcription factors, among which the liver X receptors (LXRs) and the peroxisome proliferator-activated receptors (PPARs). LXR␣, LXR␤, and PPAR␥ are ligand-activated nuclear receptors controlling cholesterol distribution and efflux, the inflammatory response 11 and, in the case of PPAR␥, macrophage polarization state. 12, 13 We have previously shown that, besides classically activated M1 macrophages, human atherosclerotic plaques contain also macrophages expressing the mannose receptor (MR), an alternative macrophage marker, suggesting heterogeneity of plaque macrophage populations. 12 However, the phenotypic characteristics and functions nor the regulatory pathways operative in these alternative M2 macrophages are still unknown. The objective of this study was to characterize the macrophage subpopulations in human atherosclerotic plaques and to study their functions.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Endarterectomy Tissue Samples
Human atherosclerotic plaques were removed from 30 patients eligible for surgical carotid endarterectomy according to the European Carotid Trialists' Collaborative Group, 14 recruited at the Cardiovascular Surgery Department, Hospital of Lille, France. 15 Informed consent was obtained from all patients.
Cell Culture
Human peripheral blood mononuclear cells were isolated from healthy donors by Ficoll density gradient centrifugation. Monocytes were differentiated into resting (RM), alternative (M2), or classic (M1) macrophages (see the Online Data Supplement). Where indicated, T0901317 (T09, 1 mol/L), 22(R)-hydroxycholesterol (22OH, 10 mol/L), GW1929 (600 nmol/L), cinnamyl-3,4dihydroxy-a-cyanocinnamate (CDC) (5 g/mL) and R04508159 (10 mol/L) compounds were added for 24 hours.
Immunohistochemical Analysis and Laser Capture Microdissection
Immunohistochemical analysis and laser capture microdissection (LCM) were performed on frozen sections (see the Online Data Supplement).
RNA Extraction and Analysis
Total cellular RNA was extracted from macrophages using TRIzol (Life Technologies, France). RNA extraction from LCM-isolated samples was performed using the Picopure RNA extraction kit (MDS Analytic Technologies). Gene expression was analyzed by quantitative polymerase chain reaction (Q-PCR) (see the Online Data Supplement).
Protein Extraction and Western Blot Analysis
Cells were harvested in lysis buffer containing PBS, 4% Triton X100, 10% Na Deoxycholate and protease inhibitors. Proteins (20 g) were separated by SDS-PAGE, transferred to Hybond-C Extra membranes (Amersham) and immunoblotted using antibodies against human LXR␣ (Abcam), human LOX-1 or ␤-actin (Santa Cruz Biotechnology). 
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Cellular Triglyceride and Cholesterol Loading
Macrophages were lipid-loaded by incubation with AcLDL or very-low-density lipoprotein (VLDL) (50 g/mL) for 48 hours or with native LDL (1 mg/mL) or oxidized LDL (50 g/mL) for 24 hours. Intracellular lipids were extracted with hexane/isopropanol (3 vol:2 vol) and triglycerides and total cholesterol measured using an enzymatic assay (Boehringer) and cholesterol distribution were measured (see the Online Data Supplement).
In certain experiments, cholesterol-loaded macrophages were stained with oil red O. Where indicated, cells were incubated with fluorescent DiI-LDL (0.2 mg/mL) for 24 hours. 16
Measurement of Cholesteryl Ester Formation
Cholesteryl ester formation was assessed by measuring the incorporation of [ 14 C]-oleate into cholesteryl esters. Human macrophages were cholesterol-loaded by incubation with AcLDL (50 g/mL) for 48 hours. After the cholesterol-loading period, cholesteryl ester formation was measured (see the Online Data Supplement).
Cholesterol Efflux
Macrophages were cholesterol-loaded by incubation with [ 3 H]cholesterol-AcLDL (50 g/mL) for 48 hours. HDL 3 and ApoAImediated cholesterol efflux was measured (see the Online Data Supplement).
Small Interfering RNA-Mediated Macrophage RNA Interference
Small interfering (si)RNA oligonucleotides corresponding to human LXR␣ and LXR␤ (Dharmacon), PPAR␥ (Ambion) sequences and scrambled control RNA oligonucleotides (Ambion) were used. RM and M2 macrophages were transfected using Dharmafect4 reagent (Dharmacon) for 16 hours and then treated for a further 24 hours with T0901317 (1 mol/L) or GW1929 (600 nmol/L).
Adenovirus Generation
The recombinant adenovirus (Ad)-GFP (Green Fluorescent Protein) and Ad-PPAR␥ were obtained as described. 17 Viral titers were determined on HEK 293 cells and defined as plaque-forming units per milliliter. Macrophages (2ϫ10 6 ) were infected for 16 hours at a multiplicity of 100 viral particles per cell and subsequently incubated for 24 hours in the absence or presence of GW1929 (600 nmol/L).
In Vitro Phagocytosis Assay
Phagocytosis tests were performed using fluorescent apoptotic cells or latex beads (see the Online Data Supplement).
Statistical Analysis
Statistical differences between groups were analyzed by Student t test and considered significant when PϽ0.05.
Results
Identification of Distinct Macrophage Subpopulations in Human Atherosclerotic Plaques
We previously reported the presence of MR-expressing macrophages in human atherosclerotic lesions. 12 However, their morphology, phenotype, and tissue localization has not been investigated yet. Therefore, macrophage-rich areas were identified by immunostaining with the pan-macrophage marker CD68, a glycoprotein located on the lysosomal membrane ( Figure 1A ). 18 Distinct macrophage subpopulations were then discriminated on the basis of coexpression of MR, an endocytic and phagocytic receptor whose expression is strongly enhanced during alternative M2 macrophage differentiation. 19 As expected, CD68 ϩ MR Ϫ macrophages were abundantly found in the lipid core of the plaque and very rarely in the intimal space. By contrast, CD68 ϩ MR ϩ macrophages were predominantly observed in the area of the plaque overlying the lipid core ( Figure 1A ). Q-PCR analysis of areas infiltrated by CD68 ϩ MR ϩ macrophages and isolated by LCM showed a higher expression of IL-4, a cytokine primarily produced by Th2 lymphocytes and inducer of macrophage alternative differentiation, compared with CD68 ϩ MR Ϫ -rich areas ( Figure 1B) .
Thus, based on morphology, localization and differential expression of the MR, human atherosclerotic lesions contain at least 2 macrophage subpopulations present in distinct, discrete zones of the plaque.
Alternative Macrophages Are Less Susceptible to Transform Into Foam Cells
Interestingly, oil red O staining revealed a different pattern of lipid droplet accumulation in CD68 ϩ MR Ϫ and CD68 ϩ MR ϩ macrophages in vivo ( Figure 1A ). Morphological comparison revealed that although CD68 ϩ MR ϩ macrophages are smaller and their cytoplasm contain several small lipid droplets (mean diameter of the lipid droplet: 1 to 1.5 m), CD68 ϩ MR Ϫ macrophages contain fewer and bigger lipid droplets (mean diameter, Ϸ15 m) ( Figure 1A ).
To investigate the mechanism behind the lower lipid accumulation observed in CD68 ϩ MR ϩ macrophages, in vitro studies were performed using human primary monocytes polarized to the M2 alternative phenotype with IL-4. As expected, the expression of the M2 macrophage markers MR, AMAC-1, and IL-1 receptor antagonist was strongly induced by IL-4, compared to resting macrophages (RM) (data not shown). By contrast, the expression of the specific dendritic cell marker CD1a was almost undetectable in M2 macrophages, showing that dendritic cell differentiation is not induced in our model (data not shown). Expression of SR-A and CD36, 2 scavenger receptors, was similar in RM and M2 macrophages (Figure 2A and 2B). In line, alternative differentiation of macrophages did not modify acetylated (Ac)LDL or VLDL-induced cholesterol or triglyceride accumulation ( Figure 2C and 2D).
Interestingly, M2 macrophages displayed a lower gene expression level of LOX-1 and caveolin-1 compared to RM ( Figure 2E and 2G ). Both the pro-(Ϸ50 kDa) and mature (Ϸ30 kDa) LOX-1 protein forms were lower expressed in M2 than in RM macrophages ( Figure 2E ). In line, M2 macrophages exhibited a reduced accumulation of oxidized and native LDL ( Figure 2F Macrophage foam cell formation induced by native LDL might occur through receptor-independent fluid phase pinocytosis, a process highly stimulated by the PKA activator PMA. 20 However, LDL accumulation in M2 macrophages was similar as in RM on PMA activation, thus excluding a defective fluid phase pinocytosis (Online Figure II) . Altogether, M2 alternative macrophages accumulate less oxidized and native LDL, an effect likely contributing to the lower accumulation of cytoplasmic lipid droplets in CD68 ϩ MR ϩ macrophages observed in vivo.
Human Alternative Macrophages Display a Lower Cholesterol Efflux Capacity
To determine whether alternative differentiation may influence the reverse cholesterol transport pathway, the impact of M2 differentiation on the expression of key genes involved in cholesterol efflux such as ABCA1 and ApoE, was studied ( Figure 3A and 3B). The expression of both genes was significantly lower in M2 macrophages compared to RM and proinflammatory M1 macrophages (Online Figure II) , suggesting that M2 macrophages may have lower cholesterol efflux capacities. CD68 ϩ MR ϩ macrophage-rich areas of human atherosclerotic plaques exhibit lower levels of ABCA1 mRNA ( Figure 3C ), protein ( Figure 3E ), and ApoE mRNA ( Figure 3D ) compared to CD68 ϩ MR Ϫ -rich zones.
In line, ApoAI-and HDL 3 -mediated cholesterol efflux was significantly lower in [3H]cholesterol-AcLDL-loaded M2 macrophages compared to RM macrophages ( Figure 3F ), indicating that alternative differentiated macrophages display impaired cholesterol efflux capacities.
Alternative Macrophage Differentiation Leads to an Increased Cholesteryl Ester Content and Cholesteryl Ester Formation
Increased macrophage cholesterol esterification capacity is a protective mechanism to control free cholesterol toxicity in conditions in which the cholesterol efflux pathway is defective. 21 We sought to determine whether the reduced cholesterol efflux capacity in M2 macrophages can, in turn, affect cholesterol esterification. Expression of LAL was higher in M2 macrophages compared to RM or TNF␣-and IL-1␤-activated macrophages ( Figure 4A ; Online Figure III, B ), suggesting enhanced lysosomal cholesteryl ester hydrolysis in M2 macrophages and higher unesterified cholesterol availability for intracellular trafficking. In line, the expression of the cholesterol transporter Niemann Pick type C 1 (NPC-1) 22 was higher in M2 compared to RM (data not shown). Moreover, intracellular cholesterol esterification ( Figure 4D and 4E) was higher in M2 macrophages, which correlated with increased ACAT-1 mRNA levels in M2 macrophages, both in vivo and in vitro ( Figure 4B 
LXR␣ Expression and Activity Is Decreased in Alternative Macrophages
Because ABCA1 and ApoE are well-known LXR target genes, 11 we investigated the expression of LXR␣ and LXR␤. LXR␣ mRNA ( Figure 5A ) and protein ( Figure 5C ), but not LXR␤ expression ( Figure 5B ) were significantly lower in M2 macrophages compared to RM or IL-1␤ and TNF␣ proinflammatory M1 macrophages (Online Figure III, F) . A lower -1 (B) , and CPT-1 (F) mRNA in RM and M2 macrophages, normalized to cyclophilin mRNA and expressed as meansϮSD relative to RM set at 1 from 3 independent experiments. Statistically significant differences are indicated (t test; ***PϽ0.001). C, Q-PCR analysis of ACAT-1 performed on RNA from LCMisolated CD68 ϩ MR Ϫ -and CD68 ϩ MR ϩ macrophage-rich areas isolated from 7 samples. mRNA levels were normalized to cyclophilin mRNA and expressed relative to the levels in CD68 ϩ MR Ϫ area set at 1. Each point corresponds to a single atherosclerotic plaque. Median value is shown. D, RM or M2 macrophages were loaded with [ 3 H]cholesterol AcLDL and lipids extracted and separated by TLC. Spots corresponding to cholesteryl ester and free cholesterol were scraped, and radioactivity was measured. Results are expressed relative to untreated cells set as 1 as meansϮSD of triplicate determinations obtained from 4 independent macrophage preparations. E, RM or M2 macrophages were cholesterol-loaded with AcLDL, and cholesteryl ester formation was measured by incubation with [ 14 C]oleic acid. Intracellular lipids were extracted and separated by TLC. Spots corresponding to cholesteryl oleate and oleic acid were scraped and radioactivity measured. Cholesteryl ester formation was calculated as percentage of [ 14 C]oleate incorporated into cholesteryl esters. Results are expressed relative to untreated cells set as 1 as meansϮSD of triplicate determinations obtained from 4 independent macrophage preparations. expression level of LXR␣ mRNA and protein was also observed in vivo in CD68 ϩ MR ϩ macrophage-rich areas of human atherosclerotic plaques ( Figure 5D and 5E).
To determine the capacity of M2 macrophages to respond to LXR activation, differentiated macrophages were incubated with the highly active synthetic dual LXR␣/␤ agonist T0901317. 23 Pharmacological LXR activation in M2 macrophages enhanced LXR␣, ABCA1 and ApoE gene expression to levels comparable to untreated RM macrophages, but much lower than in T0901317-activated RM macrophages ( Figure  6 ). In line, M2 macrophages were less sensitive than RM to the activation by the natural LXR agonist 22-hydroxycholesterol (22OH) (Online Figure V) . 24 LXR activation did not affect the macrophage alternative phenotype, because the expression of MR was unchanged (Online Figure IV) . To determine the role of LXR␣ and LXR␤ in M2 macrophage function, their expression was silenced by siRNA in M2 macrophages resulting in Ϸ70% reduction (in comparison with control siRNA-transfected cells; Figure 6E and 6L). LXR␤-silencing did not affect T0901317-induced expression of LXR␣, ABCA1 or ApoE, indicating that the observed responses are LXR␣-dependent ( Figure 6F, 6G, and 6H ). LXR␣-silencing affected the basal as well as the T0901317induced expression of LXR␣ itself, ABCA1 and ApoE, without affecting the LXR␤ expression ( Figure 6I, 6L, 6M,  and 6N ). These results indicate that LXR␣ is the LXR isoform controlling M2 macrophage cholesterol metabolism and that its low expression in these cells is involved in the decreased cholesterol handling properties. 15 -Lipoxygenase (15-LOX) is a lipid peroxidating enzyme responsible for the conversion of arachidonic and linoleic acid into 13-hydroxyoctadecadienoic (13-HODE). 15-LOX expression is strongly induced by IL-4. 25 Because 12/15-lipoxygenase transgenic mouse macrophages display reduced ABCA1 expression and cholesterol efflux, 26 a phenotype similar to the one observed in human M2 macrophages, the potential involvement of human 15-LOX in the regulation of LXR␣ signaling in M2 macrophages was assessed.
IL-4 Decreases LXR␣ Expression via a Mechanism Involving 15-Lipoxygenase
Interestingly, 15-LOX gene expression was elevated in M2 macrophages in vitro (Online Figure VI) and 15-LOX protein was higher in CD68 ϩ MR ϩ macrophages compared to CD68 ϩ MR Ϫ macrophage-rich areas in atherosclerotic plaques ( Figure 7A ). Expression of 15-LOX (blue) colocalized with MR (red), leading to purple staining ( Figure 7A ). Inhibition of 15-LOX activity in M2 macrophages with 2 different chemical inhibitors, CDC and R04508159, 27, 28 resulted in an increased expression of LXR␣ and its target genes ABCA1 and ApoE (Figure 7B through 7G) . Taken together, these results indicate that the decreased LXR␣ expression and activity in M2 macrophages is likely related to an enhanced 15-LOX activity.
Expression of Genes Involved in Phagocytosis Is Altered in Alternative Macrophages
To determine whether other macrophage functions, such as phagocytosis, are operative in CD68 ϩ MR ϩ macrophages, the expression of several key genes involved in this pathway was analyzed both in vivo and in vitro. The expression of C1qa, C1qb, C1qc, GAS-6, and TSP-1 was higher in vivo when comparing CD68 ϩ MR ϩ macrophages to CD68 ϩ MR Ϫ macrophage-rich areas of atherosclerotic plaques (Online Figure  VII, A through F) . Interestingly, this gene expression profile is comparable to the one observed in vitro in M2 macrophages, compared to RM, with the exception of MERTK, which is drastically lower on M2 polarization (Online Figure  VII , G through M). Among these, TSP-1 gene was the highest expressed in CD68 ϩ MR ϩ macrophage-rich areas in vivo (Online Figure VII, F) . These results suggest that CD68 ϩ MR ϩ macrophages likely have enhanced phagocytic activities.
PPAR␥ Activation Enhances Phagocytic Activity of Alternative Macrophages
To assess functional phagocytic activities, engulfment of fluorescent apoptotic cells or beads was determined. M2 macrophages displayed an increased capacity of phagocytosis compared to RM macrophages (Figure 8A and 8B) and this effect was enhanced by PPAR␥ activation (Figure 8C and 8D). Because TSP-1 is highest expressed in vivo (median valueϭ3.25), and given its role in phagocytosis, 29, 30 we investigated whether it is regulated by LXR␣ and PPAR␥. Whereas TSP-1 expression was not altered on LXR activation of IL-4 driven-alternative macrophages in vitro (data not shown), its expression was enhanced by PPAR␥ activation with GW1929 ( Figure 8E) , an effect which was abolished on PPAR␥ siRNA-silencing ( Figure 8F) . Moreover, infection of macrophages with an adenovirus coding for PPAR␥ (Ad-PPAR␥) increased TSP-1 expression 3.5-fold, which was further enhanced by GW1929 ( Figure 8G) . Expression of the TSP-1 receptor CD47 was higher in alternative macrophages, but not regulated by PPAR␥ ( Figure 8H ). Inhibition of TSP-1 in M2 macrophages using a blocking antibody inhibited the PPAR␥-enhanced phagocytosis activity (Online Figure VIII) .
Altogether, these results indicate that alternative macrophages display enhanced phagocytic capacity compared to RM macrophages, an effect amplified by PPAR␥ activation.
Discussion
Human atherosclerotic lesions are highly heterogeneous structures containing a variety of cell types contributing to a complex inflammatory environment. The local cytokine environment can promote differentiation of infiltrated monocytes to alternative or to classic macrophage subpopulations. We have been the first to report the presence of alternative macrophages expressing the MR within human carotid atherosclerotic plaques. 12 However, the phenotypic characterization of macrophage subpopulations within the plaques and their role in the pathogenesis of atherosclerosis has not yet been elucidated.
Immunohistological analysis shows that the macrophage subpopulations positive for CD68 and MR expression are LXR␤ (B) , ABCA1 (C), and ApoE (D) in RM or M2 macrophages treated or not with T0901317 (T09). mRNA levels were normalized to cyclophilin mRNA and expressed as meansϮSD relative to RM set at 1 from 3 independent experiments. Statistically significant differences are indicated (t test; RM vs M2: §PϽ0.05, § §PϽ0.01, § § §PϽ0.001; and T09-treated vs control: **PϽ0.01, ***PϽ0.001). E through N, Q-PCR analysis of LXR␤, LXR␣, ABCA1, and ApoE in M2 macrophages transfected with nonsilencing control (scrambled), LXR␤ siRNA (E through H), or LXR␣ siRNA (I through N) and treated or not with T0901317 (T09). Results were normalized to cyclophilin mRNA and expressed relative to the levels in control siRNA-transfected cells set at 1 (meansϮSD of 2 independent experiments). Statistically significant differences are indicated (t test; siRNA vs scrambled: §PϽ0.05, § §PϽ0.01; T09-treated vs control: *PϽ0.05, **PϽ0.01, ***PϽ0.001).
abundant in stable cell-rich areas of the atherosclerotic plaque. In contrast, CD68 ϩ MR Ϫ macrophages predominate in the lipid core of the atherosclerotic plaque and can occasionally be detected in the intimal space. We also found that CD68 ϩ MR ϩ macrophage-rich areas express higher levels of IL-4 than CD68 ϩ MR Ϫ -rich zones, thus providing the appropriate cytokine environment necessary to orient macrophage polarization. Considering that the cytokine milieu is complex and might vary during the different stages of atherosclerotic plaque progression, it is likely that intermediate spectra of differentiation states exist, with CD68 ϩ MR Ϫ and CD68 ϩ MR ϩ being the extreme situations, similar as reported for human adipose tissue macrophages. 31 However, it is of note that CD68 ϩ MR Ϫ macrophages are filled more abundantly with lipid droplets which are larger than those observed in CD68 ϩ MR ϩ macrophages. Our results using in vitro differentiated M2 macrophages indicate that these cells are less competent to take up native and oxidized lipoproteins, indicating the existence of cell-intrinsic functional differences in terms of lipid accumulation and storage.
The macrophage CD68 ϩ MR ϩ subpopulation identified in vivo shares the same features with in vitro differentiated primary monocytes in the presence of the Th2 cytokine IL-4. Moreover, these IL-4 driven alternative macrophages display a lower capacity of cholesterol efflux to extracellular acceptors, associated with reduced expression of ABCA1 and ApoE. Interestingly, the reduced cholesterol efflux capacity of alternative macrophages is probably independent of ABCG1 expression, because alternative macrophages express 2.5-fold more ABCG1 mRNA than RM macrophages (data not shown). These data are in agreement with a previous report showing that cholesterol efflux from human primary macrophage-foam cells to HDL is independent of ABCG1, but specifically requires ABCA1 expression. 32 Our results also show that, as a consequence of a defective cholesterol efflux, IL-4 -induced alternative human macrophages operate a protective mechanism against free cholesterol excess by increasing cholesterol esterification capacities, because of an induction of LAL and ACAT-1 gene expression. This latter observation is in agreement with previous results obtained in IL-4 -stimulated mouse macrophages. 33 Our results show that LXR␣, but not LXR␤, expression is much lower in alternative macrophages, both in vitro and in vivo, in CD68 ϩ MR ϩ macrophages. Previously, we reported that LXR activation in RM macrophages increases cholesterol trafficking to the plasma membrane leading to a reduced cholesteryl ester formation. 34 The increased esterification in alternative macrophages could be the consequence of the low LXR␣ activity. Indeed, pharmacological treatment of alternative macrophages in vitro with the highly active synthetic LXR ligand T0901317 and the natural ligand 22-OH cholesterol restored the expression of LXR␣ and its target genes to a level comparable to those observed in untreated RM macrophages, albeit still much lower than in T0901317-activated RM macrophages indicating that endogenous LXR␣ is limiting. Interestingly, siRNA mediated LXR␣ and LXR␤ silencing demonstrated that the responses to T091317 stimulation are mediated by LXR␣, thus identifying a specific regulatory role of the LXR␣ isoform in alternative human macrophages. Silencing of LXR␣ expression in alternative macrophages further supports this conclusion. These results are in agreement with a recent publication 35 reporting a distinct nonredundant role for LXR␣ and LXR␤ in atherosclerosis susceptibility in mice and that LXR␣ is required for a robust response to LXR ligands, such as T0901317. Of note, these effects of LXR␣ occur without affecting the alternative phenotype, because MR expression did not change on T091317 treatment. This phenotype, characterized by reduced expression of ABCA1 and cholesterol efflux, resembles the one of macrophages isolated from 12/15-LOX transgenic mice. 12/15 LOX is the homolog of human 15-LOX. However, human 15-LOX is a unique lipoxygenase, because it can oxygenate polyenoic fatty acids esterified to membrane lipids and hence may have biological roles distinct from its action on free arachidonic acid. The expression of 15-LOX is highly induced by Th2 cytokines such as IL-4 in vitro. 36 Moreover, we show that in vivo CD68 ϩ MR ϩ macrophages express higher levels of 15-LOX compared to CD68 ϩ MR Ϫ macrophages. Using 2 distinct chemical inhibitors we demonstrate that inhibition of 15-LOX in M2 macrophages restores the expression of LXR␣ and its target genes. Further studies are required to determine how and which 15-LOX-derived lipid mediators inhibit LXR␣.
Whereas CD68 ϩ MR Ϫ macrophages display a lower cholesterol handling capacity, they appear competent for phagocytosis. In line, they express higher levels of genes coding for opsonins and receptors that bridge apoptotic cells to macrophages. Notably, alternative macrophages express higher levels of C1qa, C1qb, C1qc, GAS-6 and TSP-1 than RM macrophages. Because C1q deficiency leads to defective clearance of apoptotic cells, 37 the high levels of several opsonins in alternative macrophages likely provides the molecular basis for their high phagocytotic capacity. Interestingly, although the cholesterol-handling properties are likely attributable to the reduced expression of LXR␣, the phagocytosis appears to be directly controlled by PPAR␥, whose expression is induced by IL-4 in macrophages. 38 Moreover, TSP-1, which is involved in phagocytosis, is induced by PPAR␥ in macrophages. By contrast, treatment of alternative macrophages with GW1929 did not result in the induction of the expression of ABCA1 (data not shown), whose expression is indirectly induced via LXR␣ induction in RM. 39 Thus, in alternative macrophages, PPAR␥ activities mediated via LXR␣ induction are deactivated, whereas the phagocytosis pathway is activated, at least in part, through the regulation of TSP-1.
In conclusion, we identified a macrophage subpopulation in human atherosclerotic plaques that presents a different morphology and localization, a functional heterogeneity related to the deactivation of the LXR␣ signaling pathway, and that is less susceptible to handle lipids and more competent for phagocytosis, an activity enhanced by PPAR␥ activation. It is tempting to speculate that these alternative macrophages may exert beneficial activities in atherosclerotic lesion development because they are less prone to transform into foam cells and more competent for cell engulfment, in addition to their antiinflammatory properties. During atherogenesis, monocytes infiltrate the subendothelial space of large arteries, where they differentiate into macro-phages, which turn into lipid-loaded foam cells. Macrophages are functionally heterogeneous cell populations that adapt their phenotype depending on the cytokine environment. Th1 cytokines promote M1 macrophage differentiation, whereas Th2 cytokines trigger an "alternative" M2 phenotype. Although M2 macrophages are present in atherosclerotic plaques, their function remains unclear. We show that M2 macrophages in atherosclerotic lesions contain smaller lipid droplets. In vitro, IL-4 -polarized M2 macrophages display a reduced capacity for cellular cholesterol efflux because of low levels of expression of the nuclear receptor LXR␣ and its target genes. In contrast, M2 macrophages express opsonins and receptors involved in phagocytosis, resulting in high phagocytic activity, which is enhanced by PPAR␥ activation. These observations lead to the identification of a distinct subpopulation of macrophages with a low susceptibility to become foam cells, but high phagocytic activity attributable to deactivation of the PPAR␥-LXR␣ and the activation of alternative PPAR␥-regulatory pathways. We speculate that these alternative M2 macrophages may exert beneficial effects during atherogenesis because they are less prone to transform into foam cells and are more competent in clearing apoptotic cells.
